SomnoMed Limited (ASX:SOM)
0.6600
-0.0300 (-4.35%)
Feb 25, 2026, 3:22 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 144.17 million as of February 25, 2026. Its market cap has decreased by -1.17% in one year.
Market Cap
144.17M
Enterprise Value
134.90M
Revenue
111.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.66
Market Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 144.17M, an increase of 309.55%. That is a compound annual growth rate of 6.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 144.17M | -14.46% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 635.58M |
| Aroa Biosurgery | 241.83M |
| Lumos Diagnostics Holdings | 222.10M |
| EMVision Medical Devices | 162.64M |
| Cleo Diagnostics | 78.01M |
| Compumedics | 69.92M |
| Micro-X | 50.83M |
| Nova Eye Medical | 48.42M |